Oasmia Pharmaceutical AB Probability of Future Pink Sheet Price Finishing Over 0.06
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Oasmia |
Oasmia Pharmaceutical Target Price Odds to finish over 0.06
The tendency of Oasmia Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.06 | 90 days | 0.06 | about 77.81 |
Based on a normal probability distribution, the odds of Oasmia Pharmaceutical to move above the current price in 90 days from now is about 77.81 (This Oasmia Pharmaceutical AB probability density function shows the probability of Oasmia Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 3.6 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Oasmia Pharmaceutical will likely underperform. Additionally Oasmia Pharmaceutical AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Oasmia Pharmaceutical Price Density |
| Price |
Predictive Modules for Oasmia Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oasmia Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oasmia Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oasmia Pharmaceutical is not an exception. The market had few large corrections towards the Oasmia Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oasmia Pharmaceutical AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oasmia Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 3.60 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.0007 |
Oasmia Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oasmia Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oasmia Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oasmia Pharmaceutical is not yet fully synchronised with the market data | |
| Oasmia Pharmaceutical has some characteristics of a very speculative penny stock | |
| Oasmia Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M). | |
| Oasmia Pharmaceutical generates negative cash flow from operations |
Oasmia Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oasmia Pink Sheet often depends not only on the future outlook of the current and potential Oasmia Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oasmia Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 448.4 M | |
| Shares Float | 134.6 M |
Oasmia Pharmaceutical Technical Analysis
Oasmia Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Oasmia Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oasmia Pharmaceutical AB. In general, you should focus on analyzing Oasmia Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Oasmia Pharmaceutical Predictive Forecast Models
Oasmia Pharmaceutical's time-series forecasting models is one of many Oasmia Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oasmia Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Oasmia Pharmaceutical
Checking the ongoing alerts about Oasmia Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oasmia Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oasmia Pharmaceutical is not yet fully synchronised with the market data | |
| Oasmia Pharmaceutical has some characteristics of a very speculative penny stock | |
| Oasmia Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M). | |
| Oasmia Pharmaceutical generates negative cash flow from operations |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |